173 related articles for article (PubMed ID: 38245620)
1. Risk factors for new renal scarring in children with vesicoureteral reflux receiving continuous antibiotic prophylaxis.
Su D; Zhuo Z; Zhang J; Zhan Z; Huang H
Sci Rep; 2024 Jan; 14(1):1784. PubMed ID: 38245620
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for breakthrough urinary tract infection in children with vesicoureteral reflux receiving continuous antibiotic prophylaxis.
Su D; Shen Q; Zhai Y; Chen J; Rao J; Miao Q; Tang X; Zhang Z; Liu J; Liu J; Xu H; Fang X
Transl Pediatr; 2022 Jan; 11(1):1-9. PubMed ID: 35242647
[TBL] [Abstract][Full Text] [Related]
3. Renal scarring is the most significant predictor of breakthrough febrile urinary tract infection in patients with simplex and duplex primary vesico-ureteral reflux.
Loukogeorgakis SP; Burnand K; MacDonald A; Wessely K; De Caluwe' D; Rahman N; Farrugia MK
J Pediatr Urol; 2020 Apr; 16(2):189.e1-189.e7. PubMed ID: 31953013
[TBL] [Abstract][Full Text] [Related]
4. The Swedish infant high-grade reflux trial: UTI and renal damage.
Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of the Index Urinary Tract Infection to Prophylactic Antibiotics Is a Predictive Factor of Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux Receiving Continuous Antibiotic Prophylaxis.
Lee JN; Byeon KH; Woo MJ; Baek HS; Cho MH; Jeong SY; Lee SM; Ham JY; Ha YS; Kim HT; Yoo ES; Kwon TG; Chung SK
J Korean Med Sci; 2019 Jun; 34(21):e156. PubMed ID: 31144480
[TBL] [Abstract][Full Text] [Related]
6. Girls and renal scarring as risk factors for febrile urinary tract infection after stopping antibiotic prophylaxis in children with vesicoureteral reflux.
Nakamura M; Moriya K; Kon M; Nishimura Y; Chiba H; Kitta T; Shinohara N
World J Urol; 2021 Jul; 39(7):2587-2595. PubMed ID: 33388912
[TBL] [Abstract][Full Text] [Related]
7. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.
Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S
J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
9. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction.
Herz D; Merguerian P; McQuiston L
J Pediatr Urol; 2014 Aug; 10(4):650-4. PubMed ID: 25155409
[TBL] [Abstract][Full Text] [Related]
10. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
[TBL] [Abstract][Full Text] [Related]
11. Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics.
Park S; Song SH; Lee C; Kim JW; Kim KS
Urology; 2013 Jun; 81(6):1342-5. PubMed ID: 23562584
[TBL] [Abstract][Full Text] [Related]
12. Retrospective Analysis to Determine the Optimal Timing to Discontinue Continuous Antibiotic Prophylaxis in Patients with Primary Vesicoureteral Reflux.
Anraku T; Obara K; Tasaki M; Tomita Y
Urol Int; 2019; 102(4):462-467. PubMed ID: 30917379
[TBL] [Abstract][Full Text] [Related]
13. The additive impact of the distal ureteral diameter ratio in predicting early breakthrough urinary tract infections in children with vesicoureteral reflux.
Troesch VL; Wald M; Bonnett MA; Storm DW; Lockwood GM; Cooper CS
J Pediatr Urol; 2021 Apr; 17(2):208.e1-208.e5. PubMed ID: 33500223
[TBL] [Abstract][Full Text] [Related]
14. Downgrading of high-grade vesicoureteral reflux is a reliable option in the treatment of children with grade IV‒V reflux accompanied by breakthrough infections.
Kocherov S; Arafeh WA; Zeldin A; Ostrovsky IA; Ioscovich A; Farkas A; Chertin B
J Pediatr Urol; 2013 Apr; 9(2):212-6. PubMed ID: 22391110
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for renal scarring and clinical morbidity in children with high-grade and low-grade primary vesicoureteral reflux.
Mathias S; Greenbaum LA; Shubha AM; Raj JAM; Das K; Pais P
J Pediatr Urol; 2022 Apr; 18(2):225.e1-225.e8. PubMed ID: 35094942
[TBL] [Abstract][Full Text] [Related]
16. What is the risk of urinary tract infection in children with antenatally presenting dilating vesico-ureteric reflux?
Evans K; Asimakadou M; Nwankwo O; Desai D; Cherian A; Mushtaq I; Cuckow P; Duffy P; Smeulders N
J Pediatr Urol; 2015 Apr; 11(2):93.e1-6. PubMed ID: 25819378
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for recurrent urinary tract infection in infants with vesicoureteral reflux during prophylactic treatment: effect of delayed contrast passage on voiding cystourethrogram.
Park S; Han JY; Kim KS
Urology; 2011 Jul; 78(1):170-3. PubMed ID: 21316084
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
Morello W; Baskin E; Jankauskiene A; Yalcinkaya F; Zurowska A; Puccio G; Serafinelli J; La Manna A; Krzemień G; Pennesi M; La Scola C; Becherucci F; Brugnara M; Yuksel S; Mekahli D; Chimenz R; De Palma D; Zucchetta P; Vajauskas D; Drozdz D; Szczepanska M; Caliskan S; Lombet J; Minoli DG; Guarino S; Gulleroglu K; Ruzgiene D; Szmigielska A; Barbi E; Ozcakar ZB; Kranz A; Pasini A; Materassi M; De Rechter S; Ariceta G; Weber LT; Marzuillo P; Alberici I; Taranta-Janusz K; Caldas Afonso A; Tkaczyk M; Català M; Cabrera Sevilla JE; Mehls O; Schaefer F; Montini G;
N Engl J Med; 2023 Sep; 389(11):987-997. PubMed ID: 37702442
[TBL] [Abstract][Full Text] [Related]
19. The impact of obesity on febrile urinary tract infection and renal scarring in children with vesicoureteral reflux.
Byun HJ; Ha JY; Jung W; Kim BH; Park CH; Kim CI
J Pediatr Urol; 2017 Feb; 13(1):67.e1-67.e6. PubMed ID: 28087230
[TBL] [Abstract][Full Text] [Related]
20. Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.
Ross I; Ahn HJ; Roelof B; Barber T; Huynh V; Rockette A; Popovic M; Chen JJ; Steinhardt G
J Pediatr Urol; 2015 Jun; 11(3):145.e1-6. PubMed ID: 25864614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
